GLOBMOD is a science and technology lab and a consultancy specializing in predictive analytics, and in evaluation models and tools for health.
GLOBMOD is a science and technology lab and a consultancy specializing in predictive analytics, and in evaluation models and tools for population health, health-economics, and planetary health. Its mission is to make sense of complex health data, synthesize heterogeneous evidence, and identify the most effective and cost-effective technologies and strategies for preventing, diagnosing, and treatin
http://www.jiaci.org/summary/vol27-issue2-num1467
JIACI · Journal of Investigational Allergology and Clinical Immunology Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain
We recently had a new health-economic evaluation study accepted for publication in the Journal of Investigational Allergology and Clinical Immunology
04/04/2016
Only very few published studies have concurrently assessed price elasticity and income elasticity of demand for healthcare, however the limited available data appear to be consistent with our recently published model results. For more accurate analyses we rely on more sophisticated proprietary methods that are currently unpublished. http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0151390
23/03/2016
A new publication: Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0151390
06/03/2016
Why not follow us also on LinkedIn (https://www.linkedin.com/company/glob-mod-sl…) and Twitter ( https://twitter.com/Health_Models)?
GLOBMOD Health Decision Science GLOBMOD uses data, science, and technology to optimize development, financing, and adoption of health technology and programs. A service provider to the global healthcare industry, GLOBMOD analyzes effectiveness, and establishes evidence. Through its portfolio of health economics, outcomes research,…
Quote of the day: "Never confuse data with evidence, or evidence with reality" - GLOBMOD
22/02/2016
Everybody is talking about IBM Watson. We are already using it to analyze health evidence & design better clinical trials & economic models. It's about the present, not the future
19/02/2016
About Zika virus: although we do have the technical capability to build very sophisticated infectious disease models, we are currently not planning to build a model for the Zika virus because we are an evidence-based lab, and the biological, epidemiological, and physiopathological evidence on Zika is far too weak to inform a meaningful simulation. Certainly models can still be useful to formulate and rule out hypotheses, in the context of wider field-based studies, and we'll certainly contribute, if asked. All we can recommend at this stage is not to panic, and be vigilant, if at risk